Oppenheimer Comments on CME Group Inc’s Q4 2019 Earnings (NASDAQ:CME)

CME Group Inc (NASDAQ:CME) – Stock analysts at Oppenheimer decreased their Q4 2019 earnings per share estimates for shares of CME Group in a research note issued to investors on Thursday, November 7th. Oppenheimer analyst O. Lau now expects that the financial services provider will post earnings per share of $1.63 for the quarter, down from their prior forecast of $1.72. Oppenheimer currently has a “Outperform” rating and a $234.00 target price on the stock. Oppenheimer also issued estimates for CME Group’s Q2 2020 earnings at $1.90 EPS, Q4 2020 earnings at $1.78 EPS and FY2020 earnings at $7.34 EPS.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.15. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the prior year, the firm earned $1.45 EPS. The firm’s quarterly revenue was up 41.3% compared to the same quarter last year.

A number of other equities research analysts have also commented on the stock. Wells Fargo & Co increased their price objective on shares of CME Group from $200.00 to $205.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Berenberg Bank lowered shares of CME Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $236.00 to $227.00 in a report on Thursday, September 19th. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, October 18th. UBS Group decreased their price objective on shares of CME Group from $220.00 to $218.00 and set a “neutral” rating on the stock in a report on Thursday, October 31st. Finally, Citigroup increased their price objective on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company. CME Group has a consensus rating of “Hold” and a consensus price target of $203.36.

Shares of CME traded up $3.13 during trading hours on Monday, hitting $204.62. The stock had a trading volume of 1,080,400 shares, compared to its average volume of 1,510,900. The company’s fifty day moving average is $207.56 and its two-hundred day moving average is $202.08. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04. CME Group has a 52 week low of $161.05 and a 52 week high of $224.91. The stock has a market capitalization of $70.96 billion, a price-to-earnings ratio of 30.00, a P/E/G ratio of 3.89 and a beta of 0.18.

Several large investors have recently made changes to their positions in CME. Buckingham Asset Management LLC raised its holdings in CME Group by 1.4% during the 2nd quarter. Buckingham Asset Management LLC now owns 3,607 shares of the financial services provider’s stock worth $700,000 after buying an additional 49 shares during the period. IHT Wealth Management LLC raised its holdings in CME Group by 1.1% during the 2nd quarter. IHT Wealth Management LLC now owns 4,404 shares of the financial services provider’s stock worth $855,000 after buying an additional 50 shares during the period. Pitcairn Co. raised its holdings in CME Group by 2.3% during the 2nd quarter. Pitcairn Co. now owns 2,239 shares of the financial services provider’s stock worth $435,000 after buying an additional 51 shares during the period. Lourd Capital LLC raised its holdings in CME Group by 3.5% during the 2nd quarter. Lourd Capital LLC now owns 1,620 shares of the financial services provider’s stock worth $314,000 after buying an additional 55 shares during the period. Finally, Garner Asset Management Corp raised its holdings in CME Group by 1.1% during the 2nd quarter. Garner Asset Management Corp now owns 5,200 shares of the financial services provider’s stock worth $1,009,000 after buying an additional 55 shares during the period. Institutional investors and hedge funds own 84.77% of the company’s stock.

In other CME Group news, insider Sean Tully sold 7,200 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the transaction, the insider now directly owns 19,923 shares in the company, valued at approximately $4,445,418.99. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $217.62, for a total transaction of $544,050.00. Following the transaction, the chief financial officer now owns 30,354 shares in the company, valued at $6,605,637.48. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,636 shares of company stock worth $3,001,008. Corporate insiders own 1.20% of the company’s stock.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Tuesday, December 10th will be given a dividend of $0.75 per share. The ex-dividend date is Monday, December 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.47%. CME Group’s payout ratio is presently 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: What is dollar cost averaging (DCA)?

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.